Sentences with phrase «with brachytherapy»

The evidence is clear: Cervical cancer is best treated with brachytherapy, a form of radiation therapy.

«Intermediate risk prostate cancer may be well controlled with brachytherapy alone.»

Not exact matches

«Contrary to expectations, the more aggressive, combined treatment did not result in superior cancer control rates at five years follow - up, indicating that men can achieve a similar survival benefit with fewer late side effects through brachytherapy alone.»

At two years after treatment, more than 57 percent of men who had normal sexual function prior to treatment reported poor sexual function after surgery, compared with 27 percent who reported poor sexual function after external beam radiation, 34 percent after brachytherapy, and 25 percent after active surveillance.

Presenting these results at the 3rd ESTRO Forum in Barcelona, Spain, today (Monday) Professor James Morris, from the Department of Radiation Oncology, Vancouver Cancer Centre, British Columbia Cancer Agency (BCCA), Vancouver, Canada, will say that the ASCENDE - RT1 trial is the first and only existing trial comparing low - dose - rate prostate brachytherapy (LDR - PB) for the curative treatment of prostate cancer with any other method of radiation therapy delivery.

The authors focused on men newly diagnosed with localized (non-metastatic) prostate cancer in 1995 - 2011 and treated with radical prostatectomy, brachytherapy, radiation therapy, or primary androgen deprivation therapy (PADT).

Results from a randomised controlled trial to compare the use of permanent radioactive implants (brachytherapy) with dose - escalated external beam radiotherapy in patients with prostate cancer show that the men who received brachytherapy were twice as likely to be cancer - free five years later.

Brachytherapy is an extremely efficient and safe radiation oncology modality, and this trial shows that it can have a wider field of applicability than simply in very localised and low risk tumours when combined with other techniques — in this case, androgen deprivation therapy and external bean radiation therapy.»

A study by researchers at Brigham and Women's Hospital (BWH) found that brachytherapy treatment was associated with better cause - specific survival and overall survival in women with cervical cancer.

The six benchmarks are: 1) HDR brachytherapy procedures are supported with the appropriate team as described in the report of the AAPM TG 59 and the American College of Radiology HDR Brachytherapy Practice Standard; 2) commissioning of the treatment unit, treatment planning system and each new source is performed by a qualified medical physicist and verified through a QA process; 3) assay of the HDR brachytherapy unit source is performed using a well - type ionization chamber with a calibration traceable to the National Institute of Standards and Technology, and this assay is performed or confirmed for each sbrachytherapy procedures are supported with the appropriate team as described in the report of the AAPM TG 59 and the American College of Radiology HDR Brachytherapy Practice Standard; 2) commissioning of the treatment unit, treatment planning system and each new source is performed by a qualified medical physicist and verified through a QA process; 3) assay of the HDR brachytherapy unit source is performed using a well - type ionization chamber with a calibration traceable to the National Institute of Standards and Technology, and this assay is performed or confirmed for each sBrachytherapy Practice Standard; 2) commissioning of the treatment unit, treatment planning system and each new source is performed by a qualified medical physicist and verified through a QA process; 3) assay of the HDR brachytherapy unit source is performed using a well - type ionization chamber with a calibration traceable to the National Institute of Standards and Technology, and this assay is performed or confirmed for each sbrachytherapy unit source is performed using a well - type ionization chamber with a calibration traceable to the National Institute of Standards and Technology, and this assay is performed or confirmed for each source change.

Factors associated with higher odds of brachytherapy use included younger age, being married, earlier years of diagnosis, earlier stage and certain SEER regions.

«A decline in brachytherapy utilization is associated with a higher rate of mortality in cervical cancer, so there's a direct relationship.»

The white paper recommends that practitioners follow relevant guidance documents and that deviation from consensus recommendations should be supported by clinical studies or pursued in the setting of a clinical trial approved by an institutional review board; that practitioners receive training in a new procedure before beginning its practice, that the training should include a practical, «hands - on» component and that all team members directly involved with the radiation therapy decisions should participate in at least five proctored cases before performing similar procedures independently; and that professional societies should accelerate the generation of new or updated guidance documents for the following disease sites and techniques: skin, central nervous system, gastrointestinal, lung or endobronchial and esophagus, and, while outside the charge of this panel, assess the need for updated guidance documents for accelerated partial breast irradiation using electronic brachytherapy.

In terms of patient survival, brachytherapy was associated with a higher four - year cause - specific survival (64.3 percent vs. 51.5 percent) and overall survival (58.2 percent vs. 46.2 percent) compared to EBRT alone.

Of the 7,359 patients identified, the researchers found that 63 percent of these women received brachytherapy in combination with EBRT, and 37 percent received EBRT alone.

Commissioned by ASTRO's Board of Directors as part of the Target Safely campaign, the white paper evaluates the current safety and practice guidance for HDR brachytherapy, makes recommendations for guidance applications to the delivery of HDR brachytherapy, suggests topics where additional guidance is needed and examines the adequacy of general physics, quality assurance (QA) and clinical guidance currently available for the most common treatment sites with regard to patient safety.

«High - quality brachytherapy must continue to be used, ideally with image - guidance, to maximize survival and minimize toxicity.»

The standard treatment of locally advanced cervical cancer is EBRT with concurrent chemotherapy, followed by brachytherapy.

The department maintains seven linear accelerators, a dedicated TBI system, a CT image - guided brachytherapy suite, an advanced multimodality image - guided operating (AMIGO) suite in collaboration with Interventional Radiology, and a dedicated stereotactic linear accelerator.

Working together with a multidisciplinary team of cancer specialists, our department uses highly advanced cancer care techniques including multimodality imagaing for defining tumor volume, state - of - the - art intensity modulated radiation therapy (IMRT), MRI - based treatment planning, and interstitial brachytherapy using high dosage rate treatment.

Dose Modification Factor Analysis of Multi-Lumen Brachytherapy Applicator with Monte Carlo Simulation

First Study of Its Kind Depicts Benefits of Brachytherapy for Patients with recurrent Prostate Cancer after EBRT Read more

Usual treatment of patients with stage lA2 and lB1 lesions consists of either radical hysterectomy with bilateral pelvic lymph node dissection or radiation therapy (RT), which combines two kinds of therapy — whole pelvic teletherapy and local brachytherapy (implants).